| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |